Edition:
United States

Shanghai Pharmaceuticals Holding Co Ltd (601607.SS)

601607.SS on Shanghai Stock Exchange

24.78CNY
20 Jul 2018
Change (% chg)

¥0.51 (+2.10%)
Prev Close
¥24.27
Open
¥24.37
Day's High
¥24.80
Day's Low
¥24.20
Volume
6,633,577
Avg. Vol
12,464,660
52-wk High
¥27.29
52-wk Low
¥20.81

Chart for

About

Shanghai Pharmaceuticals Holding Co., Ltd. is a China-based company principally engaged in the manufacture and sales of pharmaceuticals. The Company's businesses include the research and registration, production, sales, distribution and retailing of pharmaceutical products, among others. Its products are applied in cardiovascula... (more)

Overall

Beta: 0.93
Market Cap(Mil.): ¥63,263.73
Shares Outstanding(Mil.): 2,842.09
Dividend: 0.38
Yield (%): 1.57

Financials

  601607.SS Industry Sector
P/E (TTM): 18.62 21.43 38.60
EPS (TTM): 1.30 -- --
ROI: 10.51 11.01 46.34
ROE: 10.09 12.53 54.15

BRIEF-Shanghai Pharmaceuticals Says Q1 Net Profit Up 2.1 Percent Y/Y

April 27 Shanghai Pharmaceuticals Holding Co Ltd :

Apr 27 2018

BRIEF-Shanghai Pharmaceuticals Says Q1 Net Profit Attributable RMB1.02 Billion

April 27 Shanghai Pharmaceuticals Holding Co Ltd :

Apr 27 2018

BRIEF-Shanghai Pharmaceuticals Holding to pay cash dividend of 3.8 yuan (pre-tax) for every 10 shares

* Says it plans to pay a cash dividend of 3.8 yuan (pre-tax) for every 10 shares as the dividend payment plan for 2017

Mar 25 2018

BRIEF-Shanghai Pharmaceuticals' 2017 Net Profit Up, To Issue Bonds, Debt Financing Instruments

March 23 Shanghai Pharmaceuticals Holding Co Ltd :

Mar 23 2018

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

* Says co's Shanghai-based wholly owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration, for therapeutic biological products

Mar 05 2018

Earnings vs. Estimates